
### [NCIT:C114949](http://purl.obolibrary.org/obo/NCIT_C114949)
**Label:** Secondary Central Nervous System Hodgkin Lymphoma

**Subclasses:** [NCIT:C5057](http://purl.obolibrary.org/obo/NCIT_C5057) (Metastatic Hodgkin Lymphoma in the Cerebral Hemisphere), 

**Class expressions from DL-Learner:**

- Thing 53.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39880](http://purl.obolibrary.org/obo/NCIT_C39880) (Acinar Prostate Adenocarcinoma, Atrophic Variant))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39875](http://purl.obolibrary.org/obo/NCIT_C39875) (Loss of Chromosome 9q))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39874](http://purl.obolibrary.org/obo/NCIT_C39874) (Urethral Verrucous Carcinoma))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39873](http://purl.obolibrary.org/obo/NCIT_C39873) (Urethral Glandular Metaplasia))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39872](http://purl.obolibrary.org/obo/NCIT_C39872) (Urethral Villous Adenoma))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39866](http://purl.obolibrary.org/obo/NCIT_C39866) (Female Urethral Malignant Neoplasm))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39864](http://purl.obolibrary.org/obo/NCIT_C39864) (Carcinoma of Cowper Glands))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39862](http://purl.obolibrary.org/obo/NCIT_C39862) (Human Papillomavirus-Related Urethral Squamous Cell Carcinoma))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39859](http://purl.obolibrary.org/obo/NCIT_C39859) (Bladder Inverted Papilloma))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39856](http://purl.obolibrary.org/obo/NCIT_C39856) (Urothelial Dysplasia))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39845](http://purl.obolibrary.org/obo/NCIT_C39845) (Bladder Urachal Squamous Cell Carcinoma))) 38.30%


